ODYY — Odyssey Health, Inc.
—
OTC ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1626644 ·
Last close
$0.01
Market Cap
$706.8K
52W High
$0.08
52W Low
$0.00
ADV30
220,233
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Apr 2026 | 0 | — | -297,554 | 765,890 | 373,779 | 297,806 | 10,123,436 |
| Jan 2026 | 0 | — | -181,942 | -3,601,623 | 721,304 | 616,327 | 11,317,123 |
| Oct 2025 | 0 | — | -303,190 | -483,447 | 143,622 | 25,586 | 7,298,810 |
| Apr 2025 | 0 | — | -129,055 | -251,743 | 164,508 | 3,186 | 6,867,290 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-618,936
Investing CF
$0
Financing CF
$1,165,500
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.03
As of
2026-06-14
Balance + Analyst (yfinance extras)
Retained Earnings
$-66,830,907
Inventory
—
Receivables
—
ST Investments
—
EBIT TTM
$-3,924,348
Pretax Income TTM
$-4,556,939
Interest Exp TTM
$632,591
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Jul 2025 | — | — | — | — | — | — | — |
| Jul 2024 | 0 | -2,139,612 | -842,316 | 586,146 | 5,919,895 | — | -1,215,210 |
| Jul 2023 | 0 | -5,144,015 | -5,919,421 | 455,793 | 6,611,722 | — | -1,474,696 |
| Jul 2022 | 0 | -8,106,580 | -8,444,131 | 569,677 | 5,213,294 | — | -3,175,783 |
| Jul 2021 | 0 | -6,420,712 | -16,883,095 | 610,533 | 3,377,887 | — | -3,423,111 |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| SSKN | STRATA Skin Sciences, Inc. | $706.6K | $0.12 | — |
| NUMD | Nu-Med Plus, Inc. | $852.2K | $0.01 | — |
| LGMK | LogicMark, Inc. | $854.8K | $0.95 | — |
| PFSA | Profusa, Inc. | $1.10M | $0.24 | — |
| LYRA | Lyra Therapeutics, Inc. | $1.15M | $0.65 | — |
News headlines (Yahoo Finance, 1h cache)
Odyssey Health, Inc. Secures Exclusive Global Distribution Rights for BreastCheck™ to Drive Recurring Revenue Growth
2026-04-22 12:00 · Yahoo
Odyssey Health, Inc. Secures Multi-Million-Dollar, Nine-Year Service Contract and Financing Facility for Up to $25 Million
2025-11-19 13:30 · Yahoo
Odyssey Health, Inc., Enters the $26 Billion Breast Cancer Marketplace
2025-10-16 12:30 · Yahoo
Odyssey Health, Inc. to Advance Development of its Save A Life Choking Rescue Device
2025-08-26 12:30 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.